HK Stock MarketDetailed Quotes

BIOCYTOGEN-B (02315)

Watchlist
  • 58.550
  • -0.450-0.76%
Market Closed Apr 17 16:07 CST
26.17BMarket Cap136.48P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BIOCYTOGEN-B (02315) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
模式动物销售622.18M45.12%
临床前药理药效评估352.2M25.54%
抗体开发332.35M24.10%
基因编辑72.02M5.22%
Other52K0.00%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
模式动物销售622.18M45.12%
临床前药理药效评估352.2M25.54%
抗体开发332.35M24.10%
基因编辑72.02M5.22%
Other52K0.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
United States of America.709.76M51.48%
China438.43M31.80%
Other areas230.62M16.73%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -